IP Library Granted Patent US 8,361,756
Granted Patent B2
US 8,361,756 · App. 12/441,272 · Granted Jan 29, 2013

Bifidobacterial gene sequences and their use

Inventors: David A. Mills (Davis, CA); Carlito B. Lebrilla (Davis, CA); J. Bruce German (Davis, CA); David Sela (Davis, CA)
Assignee: The Regents of the University of California
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,361,756
App. No.
12/441,272
Granted
Jan 29, 2013
Kind
B2
Abstract

This invention provides nucleic acids and proteins involved in oligosaccharide modification in the species Bifidobacteria . The invention provides methods for utilizing the proteins of the invention to generate human milk oligosaccharides or oligosaccharide mimics. The invention also provides compositions containing the human milk oligosaccharides or oligosaccharide mimics and methods for use.

Claims (15)

1. A purified alpha-L-fucosidase polypeptide comprising an amino acid sequence at least 90% identical to the amino acid sequence encoded by SEQ ID NO: 18.

2. A method of synthesizing human milk oligosaccharides or oligosaccharide mimics, the method comprising the steps of:

(a) contacting an oligosaccharide containing precursor with the polypeptide of claim 1 ; and

(b) isolating a modified oligosaccharide containing precursor.

3. The method of claim 2 , wherein the oligosaccharide containing precursor is a carbohydrate.

4. The method of claim 2 , wherein the oligosaccharide containing precursor is a glycoprotein.

5. The method of claim 2 , wherein the oligosaccharide containing precursor is a glycolipid.

6. The method of claim 2 , wherein the oligosaccharide containing precursor has a terminal sialic acid.

7. The method of claim 2 , wherein the oligosaccharide containing precursor has a terminal fucose.

8. The method of claim 2 , wherein the oligosaccharide containing precursor has a terminal N-acetyllactosamine.

9. The method of claim 2 , wherein the oligosaccharide containing precursor is plant derived.

10. The method of claim 2 , wherein the oligosaccharide containing precursor is human derived.

11. The method of claim 2 , wherein the oligosaccharide containing precursor is animal derived.

12. The method of claim 11 , wherein the animal is bovine.

13. The polypeptide of claim 1 , wherein the polypeptide comprises the amino acid sequence encoded by SEQ ID NO:18.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 4, 2009
From: MILLS, DAVID A.; LEBRILLA, CARLITO B.; GERMAN, J. BRUCE; SELA, DAVID
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 023606/0488 →
Continuity (2)
Provisional Application 60845130 · Sep 15, 2006
Related Publication 20100113383A1 · May 6, 2010